The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effects of the novel BET inhibitor BI 894999 on upregulation of HEXIM1 in cancer cells and on antitumor activity in xenograft tumor models.
 
Ulrike Tontsch-Grunt
Employment - Boehringer Ingelheim
Patents, Royalties, Other Intellectual Property - I (as an employee of Boehringer Ingelheim) am listed as inventor on several Boehringer Ingelheim patents (Inst)
 
Fabio Savarese
Employment - Boehringer Ingelheim
 
Anke Baum
Employment - Boehringer Ingelheim
Patents, Royalties, Other Intellectual Property - Boehringer Ingelheim. Hold patents but no royalties
 
Dirk Scharn
Employment - Boehringer Ingelheim
 
Daniel Gerlach
Employment - Boehringer Ingelheim
 
Marco H. Hofmann
Employment - Boehringer Ingelheim
 
Onur Kaya
Employment - Boehringer Ingelheim
 
Norbert Schweifer
Employment - Boehringer Ingelheim
 
Harald Engelhardt
Employment - Boehringer Ingelheim
Patents, Royalties, Other Intellectual Property - Boehringer Ingelheim. Hold patents but no royalties
 
Hanny Musa
Employment - Boehringer Ingelheim
 
Chooi Peng Lee
Employment - Boehringer Ingelheim
Patents, Royalties, Other Intellectual Property - Boehringer Ingelheim
 
Gerd Michael Munzert
Employment - Boehringer Ingelheim
Patents, Royalties, Other Intellectual Property - Boehringer Ingelheim
 
Norbert Kraut
Employment - Boehringer Ingelheim
Patents, Royalties, Other Intellectual Property - Boehringer Ingelheim